Trial Profile
A phase IIa proof-of-concept study of TAC-201 in cedar pollinosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs TAC 201 (Primary)
- Indications Seasonal allergic rhinitis
- Focus Proof of concept; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 02 Jun 2016 New trial record